[{"address1": "116 Huntington Avenue", "address2": "Suite 703", "city": "Boston", "state": "MA", "zip": "02116", "country": "United States", "phone": "617 468 4219", "website": "https://www.bicara.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Bicara Therapeutics Inc., a clinical-stage biopharmaceutical company, develops bifunctional therapies for solid tumors. Its lead program is ficerafusp alfa, a bifunctional antibody that combines an epidermal growth factor receptor (EGFR) directed monoclonal antibody with a domain that binds to human transforming growth factor beta (TGF-b) for the treatment of solid tumors. The company was incorporated in 2018 and is based in Boston, Massachusetts.", "companyOfficers": [{"maxAge": 1, "name": "Ms. Claire  Mazumdar Clemon M.B.A., Ph.D.", "age": 35, "title": "CEO & Director", "yearBorn": 1989, "fiscalYear": 2023, "totalPay": 650000, "exercisedValue": 0, "unexercisedValue": 578357}, {"maxAge": 1, "name": "Mr. Ryan  Cohlhepp Pharm.D.", "age": 48, "title": "President, COO & Director", "yearBorn": 1976, "fiscalYear": 2023, "totalPay": 660000, "exercisedValue": 0, "unexercisedValue": 103783}, {"maxAge": 1, "name": "Mr. Ivan  Hyep M.B.A.", "age": 40, "title": "Chief Financial Officer", "yearBorn": 1984, "fiscalYear": 2023, "totalPay": 597500, "exercisedValue": 0, "unexercisedValue": 77109}, {"maxAge": 1, "name": "Ms. Lara S. Meisner J.D.", "age": 52, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1972, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Rachel  Salazar", "title": "SVP of R&D Strategy and Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sathish  Hasige Ph.D.", "title": "Senior VP and Head of Technical Operations & Supply Chain", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. David  Raben M.D.", "age": 61, "title": "Chief Medical Officer", "yearBorn": 1963, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Angela  Windt", "title": "VP & Head of Regulatory Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Jeltje  Schulten M.B.A., M.D.", "title": "Senior Vice President of Clinical & Medical Affairs", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Jean-Paul  Rodrique", "title": "Senior VP & Global Head of Quality Assurance", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 2, "previousClose": 13.82, "open": 14.01, "dayLow": 12.69, "dayHigh": 14.13, "regularMarketPreviousClose": 13.82, "regularMarketOpen": 14.01, "regularMarketDayLow": 12.69, "regularMarketDayHigh": 14.13, "payoutRatio": 0.0, "forwardPE": -8.0, "volume": 268012, "regularMarketVolume": 268012, "averageVolume": 424900, "averageVolume10days": 282800, "averageDailyVolume10Day": 282800, "bid": 12.75, "ask": 13.03, "bidSize": 1, "askSize": 1, "marketCap": 700872960, "fiftyTwoWeekLow": 11.1, "fiftyTwoWeekHigh": 28.09, "fiftyDayAverage": 14.9298, "twoHundredDayAverage": 19.005733, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": 231710848, "profitMargins": 0.0, "floatShares": 31305850, "sharesOutstanding": 54415600, "sharesShort": 4077688, "sharesShortPriorMonth": 4520580, "sharesShortPreviousMonthDate": 1735603200, "dateShortInterest": 1738281600, "sharesPercentSharesOut": 0.0749, "heldPercentInsiders": 0.06262, "heldPercentInstitutions": 0.86044997, "shortRatio": 10.31, "impliedSharesOutstanding": 54415600, "bookValue": 9.365, "priceToBook": 1.3753338, "lastFiscalYearEnd": 1703980800, "nextFiscalYearEnd": 1735603200, "mostRecentQuarter": 1727654400, "netIncomeToCommon": -59478000, "trailingEps": -1.09, "forwardEps": -1.61, "enterpriseToEbitda": -3.34, "52WeekChange": -0.40965402, "SandP52WeekChange": 0.2021538, "quoteType": "EQUITY", "currentPrice": 12.88, "targetHighPrice": 47.0, "targetLowPrice": 31.0, "targetMeanPrice": 39.238, "targetMedianPrice": 37.19, "recommendationMean": 1.33333, "recommendationKey": "strong_buy", "numberOfAnalystOpinions": 5, "totalCash": 520758016, "totalCashPerShare": 9.57, "ebitda": -69384000, "totalDebt": 445000, "quickRatio": 35.961, "currentRatio": 36.014, "debtToEquity": 0.087, "operatingCashflow": -52755000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BCAX", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "marketState": "REGULAR", "corporateActions": [], "regularMarketTime": 1740171074, "exchange": "NGM", "messageBoardId": "finmb_674698236", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EST", "gmtOffSetMilliseconds": -18000000, "market": "us_market", "esgPopulated": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1726234200000, "regularMarketChange": -0.9399996, "regularMarketDayRange": "12.69 - 14.13", "fullExchangeName": "NasdaqGM", "averageDailyVolume3Month": 424900, "fiftyTwoWeekLowChange": 1.7799997, "fiftyTwoWeekLowChangePercent": 0.16036034, "fiftyTwoWeekRange": "11.1 - 28.09", "fiftyTwoWeekHighChange": -15.21, "fiftyTwoWeekHighChangePercent": -0.5414738, "fiftyTwoWeekChangePercent": -40.9654, "earningsTimestampStart": 1731414649, "earningsTimestampEnd": 1731414649, "shortName": "Bicara Therapeutics Inc.", "longName": "Bicara Therapeutics Inc.", "regularMarketChangePercent": -6.8017335, "regularMarketPrice": 12.88, "isEarningsDateEstimate": false, "epsTrailingTwelveMonths": -1.09, "epsForward": -1.61, "epsCurrentYear": -2.6425, "priceEpsCurrentYear": -4.874172, "fiftyDayAverageChange": -2.0498, "fiftyDayAverageChangePercent": -0.13729587, "twoHundredDayAverageChange": -6.1257334, "twoHundredDayAverageChangePercent": -0.32230976, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-09-13", "averageAnalystRating": "1.3 - Strong Buy", "cryptoTradeable": false, "displayName": "Bicara Therapeutics", "trailingPegRatio": null, "__fetch_time": "2025-02-21"}]